• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Inspections, Compliance, Enforcement, and Criminal Investigations

  • Print
  • Share
  • E-mail
-

Section Contents Menu

Enforcement Actions

-
 

2001 Warning Letters

-

Recently Posted | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 |

Tobacco Retailer Warning Letters

 

-

Warning Letters for 2001

Recently Posted | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996

 

* Not issued: A close-out letter may issue when, based on FDA’s evaluation, the firm has taken corrective action to address the violations contained in the Warning Letter. This procedure applies to Warning Letters issued on or after September 1, 2009.

* N/A: Not applicable, the Warning Letter was issued prior to September 1, 2009.

Read more about warning and close-out letters

 
Letter Issue Date Company Name Issuing Office Subject Close Out Date
February 26, 2001 Diagnostic Imaging Associates New York District Office Mammography Standards N/A *
February 26, 2001 East Texas Medical Center-Clarksville Dallas District Office Mammography Standards N/A *
February 26, 2001 Gramercy Radiology Group P.C. New York District Office Mammography Standards N/A *
February 23, 2001 Schryver Medical Sales & Marketing Inc. Denver District Office Medical Oxygen/Adulterated N/A *
February 23, 2001 Radiology Diagnostic Centers-Frederick Baltimore District Office Mammography Standards N/A *
February 23, 2001 Wellmont Lonesome Pine Hospital Baltimore District Office Mammography Standards N/A *
February 23, 2001 Shabazz Lloyd M.D. Center for Biologics Evaluation and Research Clinical Investigator N/A *
February 23, 2001 DeJong Dairy Denver District Office Dairy/Adulterated/Illegal Drug Residue N/A *
February 23, 2001 Juweid Malik M.D. Center for Biologics Evaluation and Research Clinical Investigator N/A *
February 23, 2001 Harris Livestock Cincinnati District Office Food/Cattle/Adulterated N/A *
February 23, 2001 Peco Foods Inc. New Orleans District Office CGMP Requirements for Medicated Feeds/Animal Proteins Prohibited in Ruminant Feed N/A *
February 22, 2001 Jacoby Michael R.K. M.D. Center for Biologics Evaluation and Research Clinical Investigator N/A *
February 22, 2001 Hartville Elevator Company Inc. Cincinnati District Office Feed Mill/Animal Proteins Prohibited in Ruminant Feed/Adulterated N/A *
February 22, 2001 C.A. Griffith & Co. New York District Office Control of Communicable Diseases and Interstate Conveyance Sanitation/Airline Caterign Facility N/A *
February 21, 2001 Vitamins Classics Inc. Los Angeles District Office Food Labeling/Misbranded N/A *
February 21, 2001 United American Medical Company Inc. New Orleans District Office Quality System Regulation/Adulterated N/A *
February 20, 2001 Athens Limestone Hospital New Orleans District Office Mammography Standards N/A *
February 20, 2001 Van Dyk Holsteins Seattle District Office Food/Cattle/Adulterated N/A *
February 20, 2001 Queen of Peace Hospital Minneapolis District Office Mammography Standards N/A *
February 20, 2001 Bryan Enterprises Cincinnati District Office Feed Mill/Animal Proteins Prohibited in Ruminant Feed/Adulterated N/A *



-
 

Contact FDA

ICECI Warning Letters

Division of Freedom of Information (HFI-35)

Food and Drug Administration

5600 Fishers Lane

Rockville, MD 20857
-
-
-
-